journal article·2021-05

Robust Nanovaccine Based on Polydopamine‐Coated Mesoporous Silica Nanoparticles for Effective Photothermal‐Immunotherapy Against Melanoma

Chenlu Huang, Li Zhang, Qing Guo, Yueyue Zuo, Nannan Wang, Hai Wang, Deling Kong, Dunwan Zhu, Linhua Zhang

Advanced Functional Materials· Volume 31· Issue 18
Publisher page

Abstract

Abstract Nanoparticle‐based combination therapy strategy of photothermal therapy (PTT) and immunotherapy is an attractive cancer treatment for ablating tumors and eliciting host immune responses. However, this strategy is often hampered by tedious treatment process and limited immune response, and usually needs to be combined with checkpoint blockades to enhance therapeutic effect. Herein, a nanoplatform with mesoporous silica nanoparticles (MSNs) as a vector, which integrated photothermal agent polydopamine (PDA), model antigen ovalbumin (OVA), and antigen release promoter ammonium bicarbonate (ABC) in an easy way for melanoma PTT‐immunotherapy is designed. The formulated MSNs‐ABC@PDA‐OVA nanovaccine exhibits excellent photothermal properties and effectively eliminates primary tumors. Under laser irradiation, the MSNs‐ABC@PDA‐OVA nanovaccine realizes rapid antigen release and endosome escape, enhances dendritic cells activation and maturation, facilitates migration to tumor‐draining lymph nodes, and induces robust antitumor immune responses. Impressively, single injection of MSNs‐ABC@PDA‐OVA combines with single round of PTT successfully eradicates melanoma tumors with a cure rate of 75% and generates strong immunological memory to inhibit tumor recurrence and lung metastasis. Hence, the research offers a simple and promising strategy of synergistic PTT‐immunotherapy to effectively treat cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tianjin Key Laboratory of Biomedical Materials Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy Institute of Biomedical Engineering Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300192 China

The Key Laboratory of Bioactive Materials Ministry of Education College of Life Sciences Nankai University Tianjin 300071 China

Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy Cancer Institute Xuzhou Medical University Xuzhou Jiangsu 221004 China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities · Natural Science Foundation of Tianjin City

References (71)

Show source-provided references
1. 10.7150/thno.2407310.7150/thno.24073 ↗
2. 10.1021/ar200023x10.1021/ar200023x ↗
3. 10.1016/j.jconrel.2020.06.01510.1016/j.jconrel.2020.06.015 ↗
4. 10.1038/s41467-018-03473-910.1038/s41467-018-03473-9 ↗
5. 10.1002/smll.20180067810.1002/smll.201800678 ↗
6. 10.1016/j.biomaterials.2020.11997610.1016/j.biomaterials.2020.119976 ↗
7. 10.1038/ncomms1319310.1038/ncomms13193 ↗
8. 10.1166/jbn.2019.268510.1166/jbn.2019.2685 ↗
9. 10.1016/j.smaim.2020.09.00110.1016/j.smaim.2020.09.001 ↗
10. 10.1016/j.biomaterials.2017.08.00410.1016/j.biomaterials.2017.08.004 ↗
11. 10.1002/smll.20190263610.1002/smll.201902636 ↗
12. 10.1016/j.biomaterials.2019.11926410.1016/j.biomaterials.2019.119264 ↗
13. 10.1002/adma.20170044810.1002/adma.201700448 ↗
14. 10.1016/j.jconrel.2019.01.02710.1016/j.jconrel.2019.01.027 ↗
15. 10.1038/nrc367210.1038/nrc3672 ↗
16. 10.1021/acs.nanolett.0c0114010.1021/acs.nanolett.0c01140 ↗
17. 10.1007/s00280-019-03894-310.1007/s00280-019-03894-3 ↗
18. 10.1016/j.biomaterials.2020.11985910.1016/j.biomaterials.2020.119859 ↗
19. 10.1021/acsnano.9b0299310.1021/acsnano.9b02993 ↗
20. 10.1002/adma.20190582510.1002/adma.201905825 ↗
21. 10.1021/acsnano.8b0737110.1021/acsnano.8b07371 ↗
22. 10.1016/j.biomaterials.2020.12043110.1016/j.biomaterials.2020.120431 ↗
23. 10.1021/acsami.6b0590710.1021/acsami.6b05907 ↗
24. 10.1002/advs.20170089110.1002/advs.201700891 ↗
25. 10.1166/jbn.2019.278810.1166/jbn.2019.2788 ↗
26. 10.1038/s41563-018-0147-910.1038/s41563-018-0147-9 ↗
27. 10.1038/s41563-018-0077-610.1038/s41563-018-0077-6 ↗
28. 10.1002/adma.20180395310.1002/adma.201803953 ↗
29. 10.1021/acs.nanolett.9b0244810.1021/acs.nanolett.9b02448 ↗
30. 10.1016/j.cclet.2018.09.00610.1016/j.cclet.2018.09.006 ↗
31. 10.1038/s41563-018-0028-210.1038/s41563-018-0028-2 ↗
32. 10.1002/smll.20150366210.1002/smll.201503662 ↗
33. 10.1002/advs.20190312910.1002/advs.201903129 ↗
34. 10.1002/smll.20190704210.1002/smll.201907042 ↗
35. 10.1021/nn405809c10.1021/nn405809c ↗
36. 10.1039/c1cs15026j10.1039/c1cs15026j ↗
37. 10.1002/advs.20180015510.1002/advs.201800155 ↗
38. 10.1021/nn506679310.1021/nn5066793 ↗
39. 10.1038/s41467-019-12771-910.1038/s41467-019-12771-9 ↗
40. 10.1038/s41467-019-11269-810.1038/s41467-019-11269-8 ↗
41. 10.1021/acsami.9b0956810.1021/acsami.9b09568 ↗
42. 10.1021/acsami.7b0245710.1021/acsami.7b02457 ↗
43. 10.1016/j.ijpharm.2005.03.03510.1016/j.ijpharm.2005.03.035 ↗
44. 10.1016/j.biomaterials.2020.11984710.1016/j.biomaterials.2020.119847 ↗
45. 10.1021/acsnano.6b0469510.1021/acsnano.6b04695 ↗
46. 10.1039/C6DT03897B10.1039/C6DT03897B ↗
47. 10.1021/nn506238610.1021/nn5062386 ↗
48. 10.1029/2018JD03023710.1029/2018JD030237 ↗
49. Ding T. · NanoscaleHoriz. · 2019 · 4 · 652
50. 10.1002/adfm.20190009510.1002/adfm.201900095 ↗
51. 10.1016/j.biomaterials.2019.11947910.1016/j.biomaterials.2019.119479 ↗
52. 10.1021/acs.nanolett.7b0302110.1021/acs.nanolett.7b03021 ↗
53. 10.1016/j.jconrel.2017.11.02010.1016/j.jconrel.2017.11.020 ↗
54. 10.1016/j.biomaterials.2012.03.04110.1016/j.biomaterials.2012.03.041 ↗
55. 10.1038/nrc325810.1038/nrc3258 ↗
56. 10.1021/acs.biomac.9b0126310.1021/acs.biomac.9b01263 ↗
57. 10.1111/j.1365-3083.2007.01909.x10.1111/j.1365-3083.2007.01909.x ↗
58. 10.1016/j.coi.2013.03.00110.1016/j.coi.2013.03.001 ↗
59. 10.1016/j.jconrel.2012.03.01610.1016/j.jconrel.2012.03.016 ↗
60. 10.1038/nri167010.1038/nri1670 ↗
61. 10.1021/acs.nanolett.8b0309610.1021/acs.nanolett.8b03096 ↗
62. 10.1038/nmat298610.1038/nmat2986 ↗
63. 10.1126/science.282.5386.12110.1126/science.282.5386.121 ↗
64. 10.1016/j.biomaterials.2020.11979510.1016/j.biomaterials.2020.119795 ↗
65. 10.1111/imr.1255910.1111/imr.12559 ↗
66. 10.1021/acsnano.7b0071510.1021/acsnano.7b00715 ↗
67. 10.1038/s43018-020-0038-210.1038/s43018-020-0038-2 ↗
68. 10.1016/j.cclet.2018.06.01110.1016/j.cclet.2018.06.011 ↗
69. 10.1038/nrc.2017.1710.1038/nrc.2017.17 ↗
70. 10.1002/smll.20170062310.1002/smll.201700623 ↗
71. 10.1002/adma.20130058310.1002/adma.201300583 ↗